With advances in the understanding of the regulation of the eIF4A family, several studies have suggested that eIF4A biomarkers could be used for human cancer diagnostics and therapies (Wang et al., 2002; Shaoyan et al., 2013a). Here, EIF4A1 is linked to cancer.